Gene · 3108
Papers2,126
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,126
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Low and high serum IgG associates with respiratory infections in a young and working age population. | EBioMedicine | 2023 | 37453363 | PubTator, text mining | PubMed |
| Managing Hyperkalemia in the Modern Era: A Case-Based Approach. | Kidney Int Rep | 2023 | 37441466 | PubTator, text mining | PubMed |
| Single-cell profiling reveals distinct immune response landscapes in tuberculous pleural effusion and non-TPE. | Front Immunol | 2023 | 37435066 | PubTator, text mining | PubMed |
| Human cytomegalovirus in cancer: the mechanism of HCMV-induced carcinogenesis and its therapeutic potential. | Front Cell Infect Microbiol | 2023 | 37424781 | PubTator, text mining | PubMed |
| Race/ethnicity-stratified fine-mapping of the MHC locus reveals genetic variants associated with late-onset asthma. | Front Genet | 2023 | 37415598 | PubTator, text mining | PubMed |
| Evolutionarily conserved amino acids in MHC-II mediate bat influenza A virus entry into human cells. | PLoS Biol | 2023 | 37410798 | PubTator, text mining | PubMed |
| In Silico Analysis: HLA-DRB1 Gene's Variants and Their Clinical Impact. | Cell Transplant | 2023 | 37387418 | PubTator, text mining | PubMed |
| Identifying shared genetic loci and common risk genes of rheumatoid arthritis associated with three autoimmune diseases based on large-scale cross-trait genome-wide association studies. | Front Immunol | 2023 | 37377963 | PubTator, text mining | PubMed |
| Detection of Nonsynonymous Single Variants in Human HLA-DRB1 Exon 2 Associated with Renal Transplant Rejection. | Medicina (Kaunas) | 2023 | 37374320 | PubTator, text mining | PubMed |
| Pathophysiology of Rejection in Kidney Transplantation. | J Clin Med | 2023 | 37373823 | PubTator, text mining | PubMed |
| Checkpoint Inhibitors in Acute Myeloid Leukemia. | Biomedicines | 2023 | 37371818 | PubTator, text mining | PubMed |
| Protein Biomarker Discovery Studies on Urinary sEV Fractions Separated with UF-SEC for the First Diagnosis and Detection of Recurrence in Bladder Cancer Patients. | Biomolecules | 2023 | 37371512 | PubTator, text mining | PubMed |
| Differences in the Tumor Microenvironment of EBV-Associated Gastric Cancers Revealed Using Single-Cell Transcriptome Analysis. | Cancers (Basel) | 2023 | 37370788 | PubTator, text mining | PubMed |
| Systematic analysis of the necroptosis index in pan-cancer and classification in discriminating the prognosis and immunotherapy responses of 1716 glioma patients. | Front Pharmacol | 2023 | 37351504 | PubTator, text mining | PubMed |
| Integrative single-cell multiomics analyses dissect molecular signatures of intratumoral heterogeneities and differentiation states of human gastric cancer. | Natl Sci Rev | 2023 | 37347037 | PubTator, text mining | PubMed |
| The Role of TLR4 in the Immunotherapy of Hepatocellular Carcinoma: Can We Teach an Old Dog New Tricks? | Cancers (Basel) | 2023 | 37345131 | PubTator, text mining | PubMed |
| ALOX5AP suppresses osteosarcoma progression via Wnt/β-catenin/EMT pathway and associates with clinical prognosis and immune infiltration. | J Orthop Surg Res | 2023 | 37344882 | PubTator, text mining | PubMed |
| Peripheral blood cellular dynamics of rheumatoid arthritis treatment informs about efficacy of response to disease modifying drugs. | Sci Rep | 2023 | 37344505 | PubTator, text mining | PubMed |
| SAPrIm, a semi-automated protocol for mid-throughput immunopeptidomics. | Front Immunol | 2023 | 37334365 | PubTator, text mining | PubMed |
| SEC-seq: association of molecular signatures with antibody secretion in thousands of single human plasma cells. | Nat Commun | 2023 | 37322036 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3108/papers?page=9